PLACENTA-ASSOCIATED PLASMA PROTEIN AND FREE HUMAN CHORIONIC GONADOTROPIN LEVELS IN DAY 3 VERSUS DAY 5 TRANSFER
- 1 July 2022
- journal article
- research article
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 19 (2) , 1301-1306
Abstract
Aim: This study was conducted to investigate placenta-associated plasma protein (PAPP-A) and free human chorionic gonadotropin (B-hCG) levels after blastocyst transfer versus cleavage-stage embryo transfer. Materials and method: A total of 449 women were included in this rerospective sudy. The study consisted of two groups: Group 1: pregnant women conceived by intracytoplasmic sperm injection (ICSI) procedures after fresh embryo transfer at the cleavage stage (day 2 or day 3) and had first trimester fetal aneuploidy biochemical markers performed at 11-14th gestational week (n: 275). Group 2: pregnant women conceived by ICSI procedures after fresh embryo transfer at the blastocyst stage (day 5) and had first trimester fetal aneuploidy biochemical markers performed at 11-14th gestational week (n:174). Demographic characteristics, causes of infertility, duration of infertility, stimulation protocol regimens, total gonadotropin doses, number of follicles and oocytes retrieval, endometrial thickness, fundus –embryo distance were recorded and placenta-associated plasma protein (PAPP-A) and free human chorionic gonadotropin (B-hCG) levels were measured. Results: We found no significant differences in PAPP-A and free B-hCG levels, stimulation protocols regimens and endometrial thickness and fundus-embryo distance. Diminished ovarian reserve and total gonadotropin doses were significiantly higher in group 1 (p < 0.05). Number of follicles, number of oocytes retrieval and MII oocytes were significiantly higher in group 2 (p < 0.05). Conclusion: No difference was observed in PAPP-A and free B-hCG levels between the 3rd and the 5th day fresh transfer.Keywords
This publication has 21 references indexed in Scilit:
- Multiple meiotic errors caused by predivision of chromatids in women of advanced maternal age undergoing in vitro fertilisationEuropean Journal of Human Genetics, 2012
- Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United StatesFertility and Sterility, 2011
- First‐trimester screening markers are altered in pregnancies conceived after IVF/ICSIUltrasound in Obstetrics & Gynecology, 2008
- First‐trimester screening for trisomy 21 by free beta‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A: impact of maternal and pregnancy characteristicsUltrasound in Obstetrics & Gynecology, 2008
- Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one‐stop clinic: a review of three years experienceBJOG: An International Journal of Obstetrics & Gynaecology, 2003
- First trimester screening with free β‐hCG, PAPP‐A and nuchal translucency in pregnancies conceived with assisted reproductionPrenatal Diagnosis, 2002
- First-trimester screening for Down’s syndrome in in vitro fertilization pregnanciesFertility and Sterility, 2001
- Ultrasound and fetal chromosome abnormalitiesThe Lancet, 1992
- High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilizationJournal of Assisted Reproduction and Genetics, 1989
- IVF: Induction of ovulation in poor respondersJournal of Steroid Biochemistry, 1989